When irregularities are identified in a resident's drug regimen, the consultant pharmacist must report to whom?

When irregularities are identified in a resident's drug regimen, the consultant pharmacist must report to whom?

• A. DON, Medical Director, and attending physician
• B. DON and Medical Director
• C. Attending physician and family
• D. Attending physician

Answer: (A)

When a consultant pharmacist identifies irregularities in a resident’s drug regimen, the safest and most effective action is to escalate the issue to all key governance and care-team members. Informing the director of nursing ensures that nursing leadership and medication administration practices are reviewed and changes are coordinated at the bedside and documented in the resident’s chart. Involving the medical director provides clinical governance and ensures that the decision aligns with facility-wide medical policies and standards. The attending physician is then able to adjust orders and directly implement the necessary changes to the regimen. This trio ensures that patient safety is prioritized through timely communication, proper oversight, and clear accountability. It also helps ensure that any proposed changes are reflected in the chart, approved through the appropriate clinical authority, and carried out in the unit, reducing the risk of continuing unsafe or inappropriate therapy. Providing information to just one party can create gaps in nursing coordination, clinical governance, or medical orders, making it harder to resolve the issue effectively. Families are not typically the primary recipients for this clinical alert due to privacy and the need for professional medical decision-making.

When a consultant pharmacist identifies irregularities in a resident’s drug regimen, the safest and most effective action is to escalate the issue to all key governance and care-team members. Informing the director of nursing ensures that nursing leadership and medication administration practices are reviewed and changes are coordinated at the bedside and documented in the resident’s chart. Involving the medical director provides clinical governance and ensures that the decision aligns with facility-wide medical policies and standards. The attending physician is then able to adjust orders and directly implement the necessary changes to the regimen.

This trio ensures that patient safety is prioritized through timely communication, proper oversight, and clear accountability. It also helps ensure that any proposed changes are reflected in the chart, approved through the appropriate clinical authority, and carried out in the unit, reducing the risk of continuing unsafe or inappropriate therapy. Providing information to just one party can create gaps in nursing coordination, clinical governance, or medical orders, making it harder to resolve the issue effectively. Families are not typically the primary recipients for this clinical alert due to privacy and the need for professional medical decision-making.